FOLLICULAR LYMPHOMA, GRADE 1
Clinical trials for FOLLICULAR LYMPHOMA, GRADE 1 explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA, GRADE 1 trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA, GRADE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could fewer zaps do the job? new trial tests low-dose radiation for lymphoma
Disease control Recruiting nowThis study compares a reduced radiation dose (3 treatments) against the standard 12 treatments for people with indolent (slow-growing) non-Hodgkin lymphoma. The goal is to see if the shorter course is safer and still works well at controlling the cancer. About 112 adults with cer…
Matched conditions: FOLLICULAR LYMPHOMA, GRADE 1
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill shows promise for Tough-to-Treat lymphoma
Disease control Recruiting nowThis study tests an experimental drug called XNW5004 in 65 people with follicular lymphoma (a slow-growing blood cancer) that has returned or stopped responding to at least three prior treatments. Participants take the drug twice daily for 28-day cycles. The main goal is to see h…
Matched conditions: FOLLICULAR LYMPHOMA, GRADE 1
Phase: PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC